RANKL system in vascular and valve calcification with aging

Area of Science:

• Cardiovascular Biology
• Biochemistry
• Pathology

Background:

• Vascular and cardiac valve calcification are linked to cardiovascular mortality.
• Inflammation is increasingly recognized as a driver of calcification, sharing molecular pathways with bone metabolism.
• Key proteins like osteopontin (OPN), osteoprotegerin (OPG), RANKL, and alkaline phosphatase (ALP) are implicated in vascular and valve calcification.

Purpose of the Study:

• To explore the role of inflammation and bone metabolism molecules in vascular and cardiac valve calcification.
• To discuss the implications of plaque calcification stability for cardiovascular events.
• To highlight the need for advanced characterization and quantification for effective treatment.

Main Methods:

• Review of clinical and experimental evidence linking inflammation, bone metabolism, and calcification.
• Analysis of the roles of specific proteins (OPN, OPG, RANKL, ALP) in calcification processes.
• Evaluation of pathological findings regarding plaque stability and calcification levels.

Main Results:

• Inflammation accelerates vascular and cardiac valve calcification through shared bone metabolism pathways.
• Proteins such as OPN, OPG, RANKL, and ALP are central to calcification or demineralization.
• Heavily calcified plaques may indicate stability, while vulnerable plaques are often noncalcified or less calcified.

Conclusions:

• Abnormal protein balance contributes to vascular and valve calcification.
• The relationship between calcification and plaque stability complicates treatment approaches.
• Accurate detection, characterization, and quantification of calcification are crucial for future therapeutic strategies.